Report

rss

Iraq News

Kurdistan

Economy

World

All News

How to keep the Covid vaccine at a cold enough temperature

Category: World

Date: 2020-12-12T14:59:33+0000
How to keep the Covid vaccine at a cold enough temperature

Shafaq News/ The United States said it authorized the use of Pfizer Inc’s COVID-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in a country where the pandemic has killed more than 295,000 people.

The U.S. Food and Drug Administration granted an emergency use authorization for the vaccine, developed with German partner BioNTech, which was shown to be 95% effective in preventing the disease in a late-stage trial. It said the vaccine can be given to people aged 16 and older.

BioNTech Chief Executive Ugur Sahin said the vaccine “will help to save lives across the United States and could accelerate a return to normality.”

U.S. health authorities, shipping services, hospitals and pharmacies have been readying a nationwide inoculation campaign. Pfizer said it would start shipping immediately and state public health systems have been planning to begin shots as early as Monday.

BioNTech began developing the vaccine in January, using a technology called synthetic messenger RNA (mRNA) that had yet to produce an approved product. The technology uses a chemical messenger to instruct cells to make proteins that mimic part of the new coronavirus, which the immune system learns to recognize as an invader. BioNTech struck a development deal with Pfizer in March.

The vaccine comes with complex distribution challenges as it must be shipped and stored at -70 Celsius (-94 F), requiring specialized ultra-cold freezers or supplies of dry ice.

Pfizer has developed a special shipping container that will be filled with dry ice to keep the vaccine from spoiling. Many states are concerned about whether there is enough dry ice for shipments to rural areas that lack the specialized freezers, but Pfizer believes there should be sufficient supply.

The special transport box is at the size of a suitcase, packed with dry ice and installed with GPS trackers. Each reusable box can keep up to 5,000 doses of the vaccine at the right temperature for 10 days, if it remains unopened.

Wiltshire-based firm Polar Thermals makes similar boxes for other vaccines and counts Pfizer among its clients, but not yet for this particular purpose.

The box is not likely to be cheap. Head of sales Paul Harrison says a standard chilled transport box, which will retain a temperature of up to -8C for five days and is big enough to hold 1,200 vaccines, costs about £5,000 per unit - although they can be reused thousands of times.

His firm uses aerogel as insulation, rather than dry ice - which could be handy if a global carbon dioxide shortage from earlier this year continues to affect the availability of related products, such as dry ice.

 

 

related

Impact of COVID-19 will be felt for decades.. WHO says

Date: 2020-07-31 16:00:45
Impact of COVID-19 will be felt for decades.. WHO says

NES lockdowns a village after COVID-19 outbreak

Date: 2021-04-05 18:16:11
NES lockdowns a village after COVID-19 outbreak

Thousands are signing up to be deliberately exposed to Covid-19

Date: 2020-10-12 20:19:02
Thousands are signing up to be deliberately exposed to Covid-19

Pfizer says it's time for a Covid booster; FDA and CDC there is no need

Date: 2021-07-09 06:12:54
Pfizer says it's time for a Covid booster; FDA and CDC there is no need

First Brit to catch Covid in Wuhan died suddenly a year later

Date: 2021-02-04 07:11:27
First Brit to catch Covid in Wuhan died suddenly a year later

COVID-19 cases in France breaks the six figures threshold

Date: 2021-12-26 05:37:36
COVID-19 cases in France breaks the six figures threshold

WHO: Coronavirus cases and deaths slow in most regions

Date: 2020-08-25 18:26:20
WHO: Coronavirus cases and deaths slow in most regions

U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine

Date: 2021-08-23 15:48:25
U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine